INS and type 2 diabetes mellitus: The study explains the mechanisms of insulin resistance in sensory neurons in type 1 and type 2 diabetes, as well as the potential benefits of intrathecal injections of insulin and the neurotrophic effect of glucagon-like peptide-1 (GLP-1).